Success Metrics

Clinical Success Rate
85.6%

Based on 125 completed trials

Completion Rate
86%(125/146)
Active Trials
11(6%)
Results Posted
38%(47 trials)
Terminated
21(11%)

Phase Distribution

Ph phase_1
11
6%
Ph early_phase_1
1
1%
Ph phase_4
37
20%
Ph phase_3
55
29%
Ph phase_2
52
28%
Ph not_applicable
24
13%

Phase Distribution

12

Early Stage

52

Mid Stage

92

Late Stage

Phase Distribution180 total trials
Early Phase 1First-in-human
1(0.6%)
Phase 1Safety & dosage
11(6.1%)
Phase 2Efficacy & side effects
52(28.9%)
Phase 3Large-scale testing
55(30.6%)
Phase 4Post-market surveillance
37(20.6%)
N/ANon-phased studies
24(13.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.9%

125 of 149 finished

Non-Completion Rate

16.1%

24 ended early

Currently Active

11

trials recruiting

Total Trials

189

all time

Status Distribution
Active(17)
Completed(125)
Terminated(24)
Other(23)

Detailed Status

Completed125
unknown23
Terminated21
Recruiting9
Not yet recruiting5
Withdrawn3

Development Timeline

Analytics

Development Status

Total Trials
189
Active
11
Success Rate
85.6%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (0.6%)
Phase 111 (6.1%)
Phase 252 (28.9%)
Phase 355 (30.6%)
Phase 437 (20.6%)
N/A24 (13.3%)

Trials by Status

not_yet_recruiting53%
recruiting95%
terminated2111%
withdrawn32%
active_not_recruiting21%
completed12566%
unknown2312%
enrolling_by_invitation11%

Recent Activity

Clinical Trials (189)

Showing 20 of 189 trialsScroll for more
NCT07015905Phase 3

REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults

Recruiting
NCT07559643Not Applicable

The OAT-RCT Study: The Obesity Anti-Coagulation Thromboprophylaxis Randomised Controlled Trial.

Not Yet Recruiting
NCT06628778Phase 3

Collaborative Risk-stratified Investigation in Thrombosis-prone Inpatients With Critical Illness: Anticoagulation With LMWH in Teens for ThromboProphylaxis (CRITICAL-Teens-TP).

Not Yet Recruiting
NCT07312851Phase 1

A Study to Investigate Andexanet Dosing and the Interaction Between Andexanet and Subsequent Enoxaparin in Healthy Participants

Recruiting
NCT07462182Not Applicable

Impact of Enoxaparin Therapy on Fetal Outcomes in Intrauterine Growth Restriction

Not Yet Recruiting
NCT06454630Phase 2

A Trial to Learn How Well REGN7508 Works for Preventing Blood Clots After a Knee Replacement in Adult Participants

Completed
NCT06243510Not Applicable

Comparison of Apixaban Versus Enoxaparin

Enrolling By Invitation
NCT07140523Phase 2

A Study to Compare the Efficacy and Safety of SRSD107 and Enoxaparin in Adult Subjects Undergoing TKA

Recruiting
NCT05255003Phase 4

STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis

Recruiting
NCT01588171Not Applicable

Comparison of 2 Low Molecular Weight Heparin as a Thromboprophylaxis Postpartum

Completed
NCT05203705Phase 2

Clinical Study on the Efficacy and Safety of Multiple Oral Administrations of SHR2285 Tablets in Patients Undergoing Elective Total Knee Arthroplasty

Terminated
NCT07189897Phase 4

Apixaban or Enoxaparin After Head and Neck Cancer Surgery

Recruiting
NCT06180889Phase 2

Factor XI inhibiTion for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty

Active Not Recruiting
NCT06517563Phase 1

Effects of VMX-C001 on the Anticoagulant Effect of Different Forms of Heparin

Active Not Recruiting
NCT06118957Phase 2

Low Molecular Weight Heparin or no Treatment Following Cesarean Delivery

Completed
NCT05618808Phase 2

A Trial to Learn How Well REGN9933 Works for Preventing Blood Clots After Knee Replacement Surgery in Adult Participants

Completed
NCT04924322Phase 2

Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies

Recruiting
NCT06689241Not Applicable

Rivaroxaban Versus Enoxaparin for Prophylaxis of Venous Thromboembolism in Bariatric Surgery

Recruiting
NCT05895136Phase 2

A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT Trial).

Recruiting
NCT06818279Phase 2

Compare the Efficacy and Safety of Dabigatran and Enoxaparin in Patients With Portal Vein Thrombosis With Cirrhosis

Not Yet Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
189